Minerals Technologies Inc.
MTX Basic Materials Specialty Chemicals
Minerals Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, down 2.17% from fiscal 2024.
- Revenue
- +4.23%
- EPS
- +2.80%
- Free cash flow
- +19.0%
- Total debt
- −0.67%
Quarter to September 2026, against a year earlier
Follow MTX
Alert me
Minerals Technologies Inc. (MTX) EBITDA
Minerals Technologies Inc.'s EBITDA for fiscal 2025 was $138.6M, down 63.7% from $381.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $73.0M. Over the past ten years it has ranged from $138.6M (fiscal 2025) to $381.4M (fiscal 2024) — the current reading is the lowest in ten years. Minerals Technologies Inc. ranks 40th of 59 Specialty Chemicals companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $138.6M | (63.66%) |
| FY2024 | $381.4M | 42.95% |
| FY2023 | $266.8M | (13.66%) |
| FY2022 | $309.0M | (6.45%) |
| FY2021 | $330.3M | 17.21% |
| FY2020 | $281.8M | (8.24%) |
| FY2019 | $307.1M | (12.31%) |
| FY2018 | $350.2M | 4.41% |
| FY2017 | $335.4M | 6.21% |
| FY2016 | $315.8M | 5.76% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $92.5M | — |
| Jun 2026 | −$188.4M | — |
| Mar 2026 | $83.6M | (1.99%) |
| Dec 2025 | $85.3M | (0.23%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| FUL H. B. Fuller Company compare | $564.5M |
| KWR Quaker Houghton compare | $255.7M |
| NGVT Ingevity Corporation compare | $237.9M |
| CC The Chemours Company compare | $217.0M |
| IOSP Innospec Inc. compare | $184.5M |
| SCL Stepan Company compare | $149.2M |
| WDFC WD-40 Company compare | $119.3M |
| MTX Minerals Technologies Inc. | $73.0M |
| STDN Standard Nuclear Inc compare | — |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on MTX
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement